- September 06, 2005 – Solvay Pharmaceuticals launches DUODOPA® in 12 new European countries
Solvay Pharmaceuticals launches DUODOPA® – its treatment for advanced Parkinson’s disease – in 12 new European countries - August 02, 2005 – Solvay and Berna Biotech sign a license agreement for Aerugen®
Solvay Pharmaceuticals and Berna Biotech Ltd announce today that they have signed a commercialization and license agreement for Aerugen®, a vaccine for the prevention of Pseudomonas aeruginosa (PA) infection in Cystic Fibrosis (CF) patients. - February 20, 2025 – Solvay Pharmaceuticals Partners with Major Mexican Pharmacy
Solvay Pharmaceuticals announced today a strategic partnership with a prominent Mexican pharmacy chain based in Guadalajara, Mexico, to bring its innovative healthcare solutions, including the world-renowned pancreatic enzyme preparation Creon®, to patients across Mexico.